Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (161-170 of 760) with videos related to

Pageof 76
Sort By:
Expert Review of Cardiovascular Therapy|October 17, 2022
Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic riskPlacido Maria Mazzone, Dominick J Angiolillo, Davide Capodanno
The American Journal of Cardiology|November 22, 2012
Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndromeWilliam E Boden, Alexandra Lansky, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2020
Clopidogrel drug interactions: a review of the evidence and clinical implicationsChang Hoon Lee, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|October 11, 2023
Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?Luis Ortega-Paz, Manel Sabaté, Dominick J Angiolillo
European Heart Journal|October 28, 2022
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spotMattia Galli, Luis Ortega-Paz, Dominick J Angiolillo
Future Cardiology|July 9, 2010
Elinogrel: pharmacological principles, preclinical and early phase clinical testingMasafumi Ueno, Sunil V Rao, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|July 31, 2010
Mechanism of action and clinical development of platelet thrombin receptor antagonistsMasafumi Ueno, José Luis Ferreiro, Dominick J Angiolillo
Thrombosis and Haemostasis|March 31, 2010
Platelet function testing and risk of bleeding complicationsJosé Luis Ferreiro, Dirk Sibbing, Dominick J Angiolillo
Therapeutic Advances in Hematology|July 20, 2019
Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestationsSung Won Cho, Francesco Franchi, Dominick J Angiolillo
Future Cardiology|August 9, 2012
Atopaxar: a review of its mechanism of action and role in patients with coronary artery diseaseFabiana Rollini, Antonio Tello-Montoliu, Dominick J Angiolillo
Pageof 76

Showing results (161-170 of 760) with videos related to

Sort By:
Pageof 76
Expert Review of Cardiovascular Therapy|October 17, 2022
Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic riskPlacido Maria Mazzone, Dominick J Angiolillo, Davide Capodanno
The American Journal of Cardiology|November 22, 2012
Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndromeWilliam E Boden, Alexandra Lansky, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2020
Clopidogrel drug interactions: a review of the evidence and clinical implicationsChang Hoon Lee, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|October 11, 2023
Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?Luis Ortega-Paz, Manel Sabaté, Dominick J Angiolillo
European Heart Journal|October 28, 2022
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spotMattia Galli, Luis Ortega-Paz, Dominick J Angiolillo
Future Cardiology|July 9, 2010
Elinogrel: pharmacological principles, preclinical and early phase clinical testingMasafumi Ueno, Sunil V Rao, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|July 31, 2010
Mechanism of action and clinical development of platelet thrombin receptor antagonistsMasafumi Ueno, José Luis Ferreiro, Dominick J Angiolillo
Thrombosis and Haemostasis|March 31, 2010
Platelet function testing and risk of bleeding complicationsJosé Luis Ferreiro, Dirk Sibbing, Dominick J Angiolillo
Therapeutic Advances in Hematology|July 20, 2019
Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestationsSung Won Cho, Francesco Franchi, Dominick J Angiolillo
Future Cardiology|August 9, 2012
Atopaxar: a review of its mechanism of action and role in patients with coronary artery diseaseFabiana Rollini, Antonio Tello-Montoliu, Dominick J Angiolillo
Pageof 76